Clinical trials
Uterine Cervical Neoplasms trials in Italy with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Catholic University of the Sacred Heart | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| Advenchen Laboratories, LLC | 1 |
| Azienda Sanitaria Locale 4, Teramo | 1 |
| Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 1 |
| Cancer Prevention and Research Institute, Italy | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Hiantis Srl | 1 |
| National Cancer Institute, Naples | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 14 |
| Endometrial Neoplasms | 4 |
| Ovarian Neoplasms | 3 |
| Uterine Neoplasms | 3 |
| Fallopian Tube Neoplasms | 1 |
| Genital Neoplasms, Female | 1 |
| Neoplasm Metastasis | 1 |
| Pelvic Neoplasms | 1 |
| Postoperative Pain | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.